| 000 | 01787 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516103640.0 | ||
| 264 | 0 | _c20130103 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2012.04.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTuncer, M | |
| 245 | 0 | 0 |
_aHepatitis B surface antigen positivity is not a contraindication for living kidney donation. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _c |
||
| 300 |
_a1628-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aDonor Selection |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aGraft Rejection _xetiology |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHepatitis B _xblood |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xblood |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aLiving Donors _xsupply & distribution |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTurkey |
| 650 | 0 | 4 | _aWaiting Lists |
| 700 | 1 | _aTekin, S | |
| 700 | 1 | _aYücetin, L | |
| 700 | 1 | _aŞengül, A | |
| 700 | 1 | _aDemirbaş, A | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 44 _gno. 6 _gp. 1628-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2012.04.015 _zAvailable from publisher's website |
| 999 |
_c21981589 _d21981589 |
||